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Summary
Bbr_0838 from Bifidobacterium breve UCC2003 is
predicted to encode a 683 residue membrane protein,
containing both a permease domain that displays
similarity to transporters belonging to the major facili-
tator superfamily, as well as a CBS (cystathionine
beta synthase) domain. The high level of similarity to
bile efflux pumps from other bifidobacteria suggests
a significant and general role for Bbr_0838 in bile
tolerance. Bbr_0838 transcription was shown to be
monocistronic and strongly induced upon exposure
to bile. Further analysis delineated the transcriptional
start site and the minimal region required for pro-
moter activity and bile regulation. Insertional inacti-
vation of Bbr_0838 in B. breve UCC2003 resulted in
a strain, UCC2003:838800, which exhibited reduced
survival upon cholate exposure as compared with
the parent strain, a phenotype that was reversed
when a functional, plasmid-encoded Bbr_0838 gene
was introduced into UCC2003:838800. Transcriptome
analysis of UCC2003:838800 grown in the presence or
absence of bile demonstrated that transcription of
Bbr_0832, which is predicted to encode a macrolide
efflux transporter gene, was significantly increased in
the presence of bile, representing a likely compensa-
tory mechanism for bile removal in the absence of
Bbr_0838. This study represents the first in-depth
analysis of a bile-inducible locus in bifidobacteria,
identifying a key gene relevant for bifidobacterial bile
tolerance.
Introduction
Commensal bacteria inhabiting the human gastrointesti-
nal tract have developed strategies to tolerate the pres-
ence of deleterious substances of gastric and intestinal
origin that include bile. Bile is a mixture of organic and
inorganic compounds containing bile salts as the major
organic constituents, which are secreted into the duode-
num at a concentration ranging from 0.2% to 2% for a
given bile salt (Hofman, 1998). These compounds are
detergent-like substances that exert strong antimicrobial
activity (Begley et al., 2005), representing a key challenge
for enteric bacterial survival.
Members of the genus Bifidobacterium are inhabitants
of the human colon (Ventura et al., 2004; 2009). In recent
years, scientific evidence supporting the purported health-
promoting effects of bifidobacteria has been increasing.
Indeed, positive effects associated with the consumption
of certain bifidobacterial strains is not only observed at the
intestinal level, but also at systemic level (Lomax and
Calder, 2009). This correlation has led to certain Bifido-
bacterium strains being exploited as probiotics, and being
widely included in functional foods (Stanton et al., 2005).
For bifidobacteria to establish in the lower gastrointestinal
tract they need to survive gastrointestinal transit, and at
least transiently colonize the gut. This requirement makes
it very important to obtain a fundamental understanding of
the molecular mechanisms that confer bile tolerance to
bifidobacteria.
Bifidobacterial mechanisms of bile tolerance have
received considerable scientific attention and strains with
enhanced bile resistance have been obtained by progres-
sive adaptation to increasing concentrations of bile
(Margolles et al., 2003; Noriega et al., 2004). Remarkably,
some bile-resistant derivatives displayed cross-resistance
to other environmental stresses (Sánchez et al., 2007a,b;
2008). Among specific bile resistance mechanisms
described in enteric bacteria, bile transport and bile salt-
hydrolysing enzymes are the most frequently described
(Piddock, 2006; Jones et al., 2008). In this respect multi-
drug resistance pumps have been demonstrated to play a
significant role in bile tolerance (Piddock, 2006). These
Received 8 August, 2011; accepted 19 December, 2011. *For corre-
spondence. E-mail d.vansinderen@ucc.ie; Tel. (+353) 21 490 1365;
Fax (+353) 21 490 3101. †Present address: Laboratory of Pediatric
Infectious Diseases, Radboud University Nijmegen Medical Centre,
Nijmegen, The Netherlands. Data Deposition: The array data have
been deposited in the GEO database (Accession No. GSE31224).
Reviewers can access this data via: http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?token=dbcrrawccecgsbg&acc=GSE31224
bs_bs_banner
Microbial Biotechnology (2012) 5(4), 523–535 doi:10.1111/j.1751-7915.2011.00329.x
© 2012 The Authors
Microbial Biotechnology © 2012 Society for Applied Microbiology and Blackwell Publishing Ltd
transporters are usually involved in detoxification of a
wide variety of structurally unrelated compounds, and
have been a main focus of biomedical research due to
their clinical relevance in antibiotic resistance. However,
they are ubiquitously present in all organisms and multi-
drug efflux pumps (COG 0534) are among the gene fami-
lies that are over-represented in the gut microbiome
(Kurokawa et al., 2007; Qin et al., 2010).
Among Gram-positive bacteria, bile efflux transporters
have been described in species of Lactococcus and Lac-
tobacillus (Yokota et al., 2000; Elkins and Savage, 2003;
Zaidi et al., 2008; Pfeiler and Klaenhammer, 2009),
including both bile-inducible and constitutively expressed
genes. Relatively few studies to date have focused on
multidrug resistance transporters from Bifidobacterium.
Transporters conferring antimicrobial resistance, BbmAB
and BbmR, have been identified in Bifidobacterium breve
(Margolles et al., 2005; 2006), and bile efflux systems,
Ctr and BetA, have been described in Bifidobacterium
longum (Price et al., 2006; Gueimonde et al., 2009).
However, a significant knowledge gap remains with
respect to the molecular mechanisms underlying bile-
induced regulation of specific bile protection systems in
members of the genus Bifidobacterium, as well as their
potential role in gut survival and colonization.
Here, we report on bile-inducible genes from B. breve
UCC2003, with particular focus on Bbr_0838, and its role
in bile tolerance. Bile-induced transcriptional regulation of
Bbr_0838 was characterized, while insertional inactiva-
tion of Bbr_0838 coupled with microarray and phenotypic
analysis demonstrated the importance of Bbr_0838 as a
key bile tolerance protein. To the best of our knowledge
this work represents the first in depth report on transcrip-
tional regulation of a bile protection system in the genus
Bifidobacterium.
Results and discussion
Insertional inactivation of Bbr_0838 causes reduced bile
tolerance in B. breve UCC2003
In this study, a bile-inducible membrane protein belonging
to the MFS superfamily, Bbr_0838, which had previously
been identified on the B. breve UCC2003 genome
(Gueimonde et al., 2009), was further characterized. The
Bbr_0838 gene is located upstream of a gene predicted to
encode a serine/threonine protein kinase and down-
stream of a gene encoding a hypothetical protein
(Fig. 1A). Bbr_0838 shows extensive homology to trans-
porters from other bifidobacteria. Moreover, comparative
analysis of the surrounding areas indicates that extensive
Fig. 1. Representation of the Bbr_0838 gene and surrounding region of the B. breve UCC2003 chromosome (A). Schematic representation of
the putative membrane topology of Bbr_0838, according to TMHMM prediction. Black circles represent amino acids that constitute additional
transmembrane domains predicted by other algorithms (B). Northern hybridization analysis showing induction of monocistronic Bbr_0838
transcription by 0.06% and 0.1% of sodium cholate (C). Pin-like symbols indicate putative terminators.
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reorganization has occurred in this region (Gueimonde
et al., 2009). The gene product of Bbr_0838 is a 683
amino acid protein with an estimated molecular mass of
approximately 71 kDa. Analysis of this protein sequence
at the Expasy proteomic server (Gasteiger et al., 2003)
predicts 12 to 14 transmembrane helices, constituting a
permease domain (represented by the N-terminal 417
amino acids), and a large C-terminal hydrophilic loop that
contains a cystathionine beta synthase (CBS) pair domain
(represented by the C-terminal 166 amino acids). A sche-
matic representation of the putative membrane topology
according to TMHMM prediction (Krogh et al., 2001) is
shown in Fig. 1B.
The permease domain shares high homology with per-
meases found in other intestinal microorganisms, sug-
gesting specific relevance of this domain in this particular
environment (Gueimonde et al., 2009). CBS domains are
widely distributed in all divisions of life and are commonly
present as tandem repeats (Ignoul and Eggermont,
2005). CBS domains are frequently found to be associ-
ated with transporters and, in some cases, a regulatory
role has been described in protein trafficking and activity,
through binding of adenosyl ligands or sensing ionic
strength (Mahmood et al., 2009), although their precise
function remains unknown.
The bile-inducibility of Bbr_0838 (Fig. 1C) coupled with
its homology to reported bile efflux systems in other
bifidobacteria (> 98% identity to betA from B. longum
NCC2705) suggests a role for Bbr_0838 in supporting
B. breve UCC2003 bile tolerance. In support of this
theory, our previous work demonstrated the ability of
Bbr_0838 to enhance bile survival of recombinant
Lactococcus lactis clones expressing the Bbr_0838 (Ruiz
et al., 2011). In order to further investigate the physio-
logical role of Bbr_0838 in B. breve, two Bbr_0838
insertion mutant strains designated UCC2003::838800
and UCC2003::8381000, were constructed (see Experi-
mental procedures). Southern hybridization using EcoRI-
digested genomic DNA and pORI19-8381000-tetW as a
probe unequivocally confirmed that the disruptions of
Bbr_0838 were the result of site-specific homologous
recombination events (Fig. 2). Moreover, the stability
of the integrated plasmid in UCC2003::838800 and
UCC2003::8381000 strains was analysed following 50 gen-
erations in the absence of the selective antibiotic, showing
that at least 96% of the cells retained the insertion.
Growth characteristics of UCC2003::838800 and
UCC2003::8381000 under unstressed conditions (i.e. no
added bile) showed no difference in growth rate or
final optical density (OD) as compared with B. breve
UCC2003. In addition, preliminary phenotypic analysis of
UCC2003::838800 and UCC2003::8381000 showed that
between them they did not exhibit obvious differences
with regards to their bile resistance phenotype (data not
shown). For this reason, further experiments were per-
formed using B. breve UCC2003::838800.
To examine the effect of the Bbr_0838 mutation on bile
tolerance, a series of survival and growth experiments
were carried out in MRSc supplemented with ox-gall, or
particular components of bile. The minimal inhibitory con-
Fig. 2. Schematic representation of relevant regions of Bbr_0838 gene in B. breve UCC2003 and B. breve UCC2003::838 chromosomes.
A. Chromosomal DNA is represented by a thin line, Bbr_0838 by a black arrow, Bbr_0838 fragment employed for homologous recombination
by a grey bar and pORI19 by a dashed line. Representative EcoRI sites for Southern hybridization are indicated.
B. Southern hybridization of EcoRI digested chromosomal DNA from B. breve UCC2003 (lane 1) and 8 representative insertional mutants
(lanes 2 to 4 correspond to UCC2003::838800 clones and lanes 5 to 9 correspond to UCC2003::8381000 clones) are shown in B. Sizes of
hybridized fragments are shown at the left of the panel. pORI19-8381000-tetW was used as a probe and positive control of hybridization was
performed on lane 10.
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centrations of a complex mixture of bile salts, ox-gall and
individual bile salts, were determined during 24 h growth
experiments. The main bile acids in humans are repre-
sented by glycocholate and taurocholate, while bile acids
resulting from metabolism of bile in the intestine, are
represented by cholate, and deoxycholate. Differences in
MIC between both strains were only detected in MRSc
supplemented with cholate, where a MIC value of 0.2%
(w/v) was observed for the wild-type strain, while the
UCC2003::838800 mutant was more sensitive with a corre-
sponding MIC value of 0.1% (w/v). MICs were identical
for ox-gall (> 10%), glycocholate (0.25%), taurocholate
(> 1%) and glycodeoxycholate (0.625%). This is in accor-
dance with our recent results, in which maximum tran-
scriptional induction levels of Bbr_0838 were observed in
the presence of cholate (Ruiz et al., 2011) and were
further substantiated by growth experiments. In the pres-
ence of 0.025%, 0.05% or 0.1% (w/v) of cholate,
UCC2003::838800 exhibited slower growth and a lower
final OD at 600 nm after 24 h, as compared with
UCC2003 (Fig. 3). Enumeration of viable cells in over-
night cultures by plate counts and Dead/Live labelling
also pointed to reduced growth and cell viability of
UCC2003::838800 grown in the presence of cholate (data
not shown).
Insertional inactivation of Bbr_0838 results in a strain
that has both erythromycin and tetracycline resistance
cassettes on the genome. Although a potential role of
antibiotic resistance markers in bile tolerance would not
be expected an additional alternative insertion mutant,
UCC2003::bbr_1552 (M. O’Connell-Motherway, unpubl.
data) in a non-bile-inducible gene, encoding a predicted
b-galactosidase (Bbr_1552), was employed as a control
for the phenotypic assays. This allowed us to confirm that
the observed phenotype of low tolerance to cholate in
UCC2003::838800 was not as a consequence of the anti-
biotic resistance genes carried by the insertion mutant
strains (data not shown) but due to the insertional inacti-
vation of Bbr_0838. These observations demonstrated a
significant contribution of Bbr_0838 in bile detoxification in
B. breve UCC2003, in accordance with previous results
from the B. longum homologue, BetA (Gueimonde et al.,
2009), and suggest that cholate is the main bile compo-
nent detoxified by this system.
In order to show that the reduced bile survival pheno-
type in the insertion mutant was due to the absence of
functional Bbr_0838, we complemented UCC2003::838800
strain with a plasmid containing the structural gene.
Complementation of UCC2003::838800 with Bbr_0838
expressed from its own promoter on pBC1.2 restored the
growth in the presence of cholate and the bile resistant
phenotype to levels comparable with wild-type B. breve
UCC2003 (Fig. 4B).
To date several bile-transport-mediated bile-
detoxification systems, displaying different specificities for
different bile salts, have been characterized in Gram-
positive microorganisms (Lin et al., 2003; Lubelski et al.,
2006; Cerda-Maira et al., 2008; Watson et al., 2008;
2009; Pfeiler and Klaenhammer, 2009; Quillin et al.,
2011). However, this is the first report describing the inac-
tivation of a gene encoding a bile detoxification system in
bifidobacteria, and demonstrates the usefulness of this
KO generation system as a means to functionally charac-
terize transporters in B. breve, as has been shown previ-
ously for other proteins (O’Connell-Motherway et al.,
2008; Pokusaeva et al., 2010, 2011).
In order to determine if other genes were able to at least
partially counteract the absence of a functional Bbr_0838
in the presence of bile salts, a comparative transcriptomic
analysis of bile stress response in both wild-type and
UCC2003::838800 strains was performed. No significant dif-
ferences were revealed by whole-genome microarray
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Fig. 3. Growth of B. breve UCC2003 and B. breve UCC2003::838800 in medium containing different sodium cholate (CA) concentrations,
ranging from 0% to 0.1% (w/v), measured through OD at 600 nm. Data are mean of three independent experiments.
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analysis, although the absence of transcriptional induction
of Bbr_0838 was confirmed in the mutant strain. Analysis
by q-RT-PCR showed that significant differences in bile-
induction levels of selected transporters (previously
shown to be induced by bile, Ruiz et al., 2011), were not
detected. Nevertheless, significant differences in basal
expression levels between the wild-type and the mutant
strains were detected in the particular case of Bbr_0832,
which exhibited basal expression levels that were 5.8
times higher in the mutant strain compared with the wild-
type UCC2003 (Fig. 5).
The ORF Bbr_0832 is homologous to genes encoding
macrolide efflux transporters, and has been demonstrated
to be bile-inducible (Ruiz et al., 2011). In view of this, we
speculate that Bbr_0832 overexpression in the B. breve
UCC2003::838800 mutant strain is contributing to some
extent to the bile survival phenotype by counteracting the
impact of Bbr_0838 inactivation on bile response.
Characterization of the Bbr_0838 promoter and analysis
of the region involved in its bile-inducibility
In order to characterize the Bbr_0838 promoter region
and identify regulatory regions responsible for its bile-
inducible behaviour, various transcriptional fusions with
gusA were constructed using the promoter probe vector
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Fig. 4. Restoration of wild-type phenotype in the complemented mutant strain.
A. Growth curves in the presence of different cholate concentrations are presented for the complemented strain (UCC2003::838800-pBC838)
and for the mutant strain containing pBC1.2 as a control (UCC2003::838800-pBC1.2). Presented data are means of three independent
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pNZ272 (see Experimental procedures). pNZ272 was
originally designed to analyse promoters in Lactobacillus
and related microorganisms (Platteeuw et al., 1994) and
has previously been successfully used to analyse promot-
ers in B. breve UCC2003 (Ventura et al., 2005). The
various fragments used by us to create gusA fusions
represented DNA segments encompassing sequences of
different length between 579 bp upstream of the start
codon and 66 bp of the coding region of Bbr_0838. Bile-
induction of gene expression in the different gusA fusions
was determined through measurement of GusA activity
following overnight growth in the presence of sub-
inhibitory concentrations of sodium cholate. The region
comprising 579 bp upstream from the start codon of
Bbr_0838 was determined to be necessary for both effi-
cient mRNA synthesis and bile-inducibility. Within this
region the ribosomal binding site, the transcription start
site, the promoter region and also possible binding sites
for putative regulatory proteins may be located.
Primer extension analysis on total RNA isolated from
cells grown under sub-inhibitory concentrations of cholate
showed that the transcriptional start site (tss) is located at
a Guanine residue 375 bp upstream of the start codon of
the coding sequence. Sequences representing the puta-
tive -10 and -35 regions were located upstream from the
tss (Fig. 6). Determination of this transcriptional start site
is in accordance with the absence of gene expression in
the gusA fusion containing only 162 bp upstream from the
start codon (pNZ272-short), as the transcriptional start
site and -10 and -35 hexamers are not encompassed in
this construct (Fig. 7).
Bioinformatic analysis of the promoter region showing
transcriptional activity and bile-induced gene expression,
revealed two large inverted repeats that may have regu-
latory roles affecting either transcription or translation of
the ORF they precede. Interestingly, the high evolutionary
conservation of these repeats in different bifidobacterial
species containing gene homologues of Bbr_0838
(i.e. Bifidobacterium bifidum, Bifidobacterium adolescen-
tis and B. longum) might imply an important biological
function for this long untranslated RNA segment. In this
regard, there is increasing evidence about the role of
certain RNA structures, including long 5′ untranslated
regions (5′UTR), in transcriptional or translational regula-
tion of gene expression in bacteria (Waters and Storz,
2009). In addition to putative binding sites for regulatory
proteins, in some cases 5′UTR regions of mRNA have
been reported to autoregulate transcription or translation
of the coding region they precede. This is the case of
some riboswitches, in which secondary structures of
mRNA may act both as target site for certain ligands and
transcriptional attenuators. In this way, binding of the spe-
cific ligand to the RNA riboswitch may result in structural
changes that could turn a gene on or off (Coppins et al.,
2007). Furthermore, some UP elements, DNA fragments
located upstream from the tss and usually with a high A/T
content, have also been involved in transcriptional regu-
lation in Gram-positive bacteria (Estrem et al., 1998; Ke
et al., 2009). To determine the putative role of the large
inverted repeats on Bbr_0838 expression, gusA fusions
lacking DNA regions of variable length immediately
upstream from Bbr_0838, but retaining the region encom-
passing the presumed -35 and -10 sequences and the
transcriptional start site, were constructed and their bile-
inducibility measured through GusA activity (Fig. 7).
The obtained results showed that the DNA region
encompassing base pairs 579 and 296 bp upstream from
the start codon is sufficient for efficient mRNA synthesis
and bile-induction (construct pNZ272-296 in Fig. 7). DNA
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regions located until 296 bp upstream from the start
codon of Bbr_0838 do not seem to have any effect on
cholate induction, as induction levels in the smaller con-
structs analysed were similar to the ones measured in the
construct containing the whole promoter region (Fig. 7).
According to these results, although a role of the DNA
sequence comprising the 296 bp immediately upstream
from the start codon of Bbr_0838 (and thus the two large
inverted repeats detected within) in gene expression
regulation may not be ruled out, results from gusA fusions
Fig. 6. Schematic representation of the Bbr_0838 promoter region (B). Relevant regions and localization of primers used in Primer Extension
experiment are highlighted. A shows the primer extension results from cultures grown in the absence and presence of sodium cholate.
A B 
F
o
ld
-i
n
d
u
ct
io
n
G
u
sA
a
ct
iv
ity
Constructs
14
12
10
8
6
4
2
0
IR
tss
-204 +441
+441+214
503+402-
+232-204
+186-204
841+402-
08+402-
+441-49
Prom838
F2bglII
Prom838
F2bglIIshort
Prom838
FbglII
pNZ272-long
pNZ272-
short
pNZ272-ss
pNZ272-71
pNZ272-144
pNZ272-190
pNZ272-228
pNZ272-296
IRII
Fig. 7. Schematic representation of Bbr_0838 promoter – gusA transcriptional fusions performed in pNZ272 (A) and determination of their
inducibility by 0.025% of sodium cholate measured through b-D-glucuronidase activity (B).
529 L. Ruiz et al.
© 2012 The Authors
Microbial Biotechnology © 2012 Society for Applied Microbiology and Blackwell Publishing Ltd, Microbial Biotechnology, 5, 523–535
do not show any significance of these sequences in
Bbr_0838 bile-induced expression. In addition, absolute
values of GusA activity for constructs lacking the region
encompassing both inverted repeats were found to be
9.93  1.65 times lower compared with the construct
encompassing the complete UTR, thus suggesting a
potential involvement of these regions in mRNA stability.
The full extent of the UTR is predicted to adopt secondary
structures in RNA, where both inverted repeats signifi-
cantly contribute to the presumed structure (Fig. S1). The
potential involvement of certain secondary RNA struc-
tures in contributing to mRNA stability and, consequently
affecting efficiency of translation, either protecting RNA
against ribonucleases, affecting protein–DNA interactions
or avoiding translation initiation has been extensively
reported (Diwa et al., 2000; Hambraeus et al., 2002).
An additional gusA fusion in which a 155 bp DNA frag-
ment (comprising nucleotides -50 to -204 upstream from
the transcriptional start site) was removed from the pro-
moter sequence, while the 375 bp encompassed among
the tss and the start codon in the native sequence and the
-10 and -35 hexamers were conserved (pNZ272-ss), was
found to have lost its bile-inducibility (Fig. 7). From this
result it was concluded that bile-dependent regulatory
sequences, possibly targets for a DNA binding regulatory
protein, are present within the 155 bp region upstream
from the tss. Further research is required to investigate
the exact role of this region in controlling Bbr_0838 tran-
scription. Within this DNA segment, an A/T rich region
including two short direct repeats were detected, and their
role in the regulation of Bbr_0838 expression regulation
will be subject to future investigations.
Conclusions
Bile tolerance is an important feature for probiotic bacte-
ria, as it influences their chances of reaching and coloniz-
ing the intestine. To date some mechanisms of bile
tolerance in the genus Bifidobacterium have been
reported, although no detailed information has been
described on their genetic regulation. In this work, through
construction of an insertional mutant, a bile-inducible
transporter was demonstrated to play a role in bile toler-
ance of B. breve UCC2003. In addition, preliminary
characterization of the Bbr_0838 promoter sequence,
revealed a long 5′UTR highly conserved among intestinal
bifidobacteria, exerting an efficient, tight and complex
regulatory mechanism in which both transcriptional regu-
lators and RNA secondary structures may be involved.
The apparent universal distribution of homologues to
Bbr_0838 in intestinal bifidobacteria and the extensive
homology they share, both in the coding sequence and
corresponding promoter regions, seems to reflect the
importance of this gene in the intestinal ecosystem.
Further detailed investigations to reveal its precise regu-
latory mechanism(s) and inducing signals, as well as to
research additional and apparently compensatory bile
resistance genes and mechanisms, are ongoing and no
doubt will expand our knowledge on bifidobacterial adap-
tation to the intestinal environment.
Experimental procedures
Bacterial strains, plasmids and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Bifidobacterium breve UCC2003 was grown at 37°C
in MRS broth (Difco, BD Diagnostic Systems, Sparks, MD,
USA) supplemented with 0.05% L-cysteine (w/v) (Sigma, St
Louis, MO, USA) (MRSc) in an anaerobic chamber (Mac 500,
Don Whitley Scientific, West Yorkshire, UK) with an atmo-
sphere of 5% CO2 – 5% H2 – 90% N2. Analysis of Bifidobac-
terium tolerance to toxic compounds was performed by
supplementing MRSc before inoculation with different con-
centrations of ox-gall (Oxoid Limited, Hampshire, UK), or
a particular bile salt (cholate, glycocholate, taurocholate,
deoxycholate) supplied by Sigma. The Dead/Live labelling kit
was supplied by Invitrogen (Invitrogen, Barcelona, Spain).
Growth of Bifidobacterium strains was monitored using a
PowerWave Microplate Spectrophotometer (Biotek, UK).
Escherichia coli was cultured in Luria–Bertani (LB) broth at
37°C with agitation, and L. lactis was cultivated in M17 broth
(Oxoid) supplemented with 0.5% glucose (GM17) at 30°C.
Where appropriate, the growth medium contained chloram-
phenicol (Cm; 5 mg ml-1 for L. lactis and 2 mg ml-1 for
B. breve), erythromycin (Em; 100 mg ml-1 for E. coli), kana-
mycin (50 mg ml-1 for E. coli), ampicillin (100 mg ml-1 for
E. coli) or tetracycline (10 mg ml-1 for E. coli or B. breve)
when required for plasmid maintenance. Recombinant E. coli
cells containing pORI19-838 were selected on LB agar con-
taining Em and supplemented with 40 mg ml-1 of Xgal and
1 mM of IPTG.
Restoration of bile survival phenotype in the comple-
mented mutant strain was analysed by exposing early expo-
nential growth phase cells to different concentrations of
cholate in fresh MRSc, incubating samples at 37°C in anaero-
bic conditions and determining colony counts after several
hours of bile exposure.
Nucleotide and protein sequence analysis
Sequence data were obtained from genome annotations
of B. breve UCC2003 (O’Connell-Motherway et al., 2011).
Database searches were performed using BLAST at the
National Center for Biotechnology Information internet site
(‘http://www.ncbi.nlm.nih.gov’) and predictions of protein
topology and domains were performed at ExPasy server
(http://expasy.org) (Gasteiger et al., 2003).
DNA manipulations
Chromosomal DNA from B. breve UCC2003 was obtained
according to previously described procedures (Margolles and
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de los Reyes-Gavilán, 2003) and sequences for cloning were
amplified from B. breve chromosomal DNA using high-fidelity
Platinum PfX polymerase (Invitrogen). Plasmid miniprepara-
tions from E. coli and L. lactis were performed using spin-in-
column system (Sigma), according to the manufacturer’s
instructions, with the incorporation of an initial lysis step for
L. lactis, involving suspension of the cells in lysis buffer (20%
sucrose, 10 mM Tris-HCl pH 8.1, 10 mM EDTA and 50 mM
NaCl) supplemented with lysozyme (10 mg ml-1), followed by
incubation at 37°C for 30 min. Plasmid preparations from
B. breve were performed according to previously described
procedures (O’Connell-Motherway et al., 2009). Electropora-
tion of plasmid DNA into E. coli was carried out as described
by Sambrook and colleagues (1989), into L. lactis as
described by Wells and colleagues (1993) and into B. breve
UCC2003 was performed as reported by Mazé and col-
leagues (2007). The absence of PCR-introduced mutations
was verified in all plasmid constructs created in this study by
sequencing both DNA strands on an ABI Prism sequencer
(Applied Biosystems, Foster City, CA, USA). Southern blot
transfer of EcoRI-digested DNA from B. breve UCC2003 and
insertion mutants was performed according to standard pro-
cedures (Sambrook et al., 1989). Hybridization and detection
were carried out using the digoxigenin DNA-labelling and
detection kit (Roche Molecular Biochemicals, Lewes, UK)
according to manufacturer’s instructions.
Construction of B. breve UCC2003::838 mutant and
functional complementation
Internal 800 and 1000 bp fragments of Bbr_0838 (which cor-
responds to amino acid residues 100 to 357, and 100 to 438
respectively) were PCR-amplified using B. breve UCC2003
chromosomal DNA as a template and primer combinations
838F and 838800R, or 838F and 8381000R. Amplified products
were digested with HindIII and XbaI, and cloned into similarly
digested pORI19, to generate pORI19-838800 and pORI19-
8381000 respectively. The tetracycline (Tet) resistance antibi-
otic cassette, tet(W), from pAM4 (Álvarez-Martín et al., 2008)
was then cloned as a SacI fragment into the unique SacI site
on each of these pORI19 derivatives, yielding pORI19-838800-
tetW and pORI19-8381000-tetW respectively. These latter two
plasmids were then introduced into E. coli EC101 harbouring
pNZ-M.BbrII-M.BbrIII in order to obtain methylated plasmid
DNA as previously described (O’Connell-Motherway et al.,
2009) and such methylated plasmid preparations were used
to transform B. breve UCC2003 by electroporation. Selection
for transformants was made on Reinforced Clostridial Agar
(RCA, Oxoid) plates containing tetracycline. Transformants
were checked by PCR and Southern hybridization to confirm
whether they contained either pORI19-838800-tetW or
pORI19-8381000-tetW inserted into their chromosome, and
one verified insertion mutant for each of these events was
retained for further use and designated UCC2003::838800 and
UCC2003::8381000 respectively. The stability of these inser-
tions was analysed following 50 generations of growth in
MRSc in the absence of selective agents, by spreading cells
with and without antibiotic. Stability was expressed as the
proportion of viable cells retaining the insertion.
For mutant complementation, primers pBC-838-f and pBC-
838-r were used to PCR-amplify the region comprising the
coding sequence of Bbr_0838 under the control of its own
promoter from B. breve UCC2003 chromosomal DNA. Puri-
fied PCR product was HindIII and BamHI digested, and
ligated into similarly digested pBC1.2, yielding pBC-838,
which was transformed into B. breve UCC2003::838800 by
electroporation.
Transcriptional analysis
Differences in transcriptional response to bile stress
between B. breve UCC2003 and its derivative B. breve
Table 1. Strains and plasmids used.
Relevant phenotype or genotype Reference or source
Strains
E. coli EC101 Cloning host, repA+, Kanr Law and colleagues (1995)
B. breve UCC2003 Infant isolate MacConaill and colleagues (2003)
B. breve UCC2003::838800 pORI19-Bbr_0838 insertional mutant of B. breve UCC2003 This work
B. breve UCC2003::8381000 pORI19-Bbr_0838 insertional mutant of B. breve UCC2003 This work
L. lactis NZ9000 L. lactis MG1363 pepN::nisRK de Ruyter and colleagues (1996)
Plasmids
pORI19 Emr RepA- Ori+; cloning vector Law and colleagues (1995)
pORI19-838800-tetW Internal 800 bp fragment of Bbr_0838 cloned in pORI19 This work
pORI19-8381000-tetW Internal 1000 bp fragment of Bbr_0838 cloned in pORI19 This work
pNZ272 Cmr; gusA promoter-probe vector Platteeuw and colleagues (1994)
pNZ272-long Cmr; pNZ272 derivative; containing 0.58 kb promoter region of
Bbr_0838 translationally fused to gusA
This work
pNZ272-short Cmr; pNZ272 derivative This work
pNZ272-ss Cmr; pNZ272 derivative This work
pNZ272-71 Cmr; pNZ272 derivative This work
pNZ272-144 Cmr; pNZ272 derivative This work
pNZ272-190 Cmr; pNZ272 derivative This work
pNZ272-228 Cmr; pNZ272 derivative This work
pNZ272-296 Cmr; pNZ272 derivative This work
pBC1.2 Ampr; Cmr; E. coli-Bifidobacterium shuttle cloning vector Álvarez-Martín and colleagues (2008)
pBC-838 pBC1.2 derivative; Bbr_0838 cloned under its native promoter This work
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UCC2003::838800 were determined by microarray experi-
ments. Verification of microarray results was carried out by
quantitative reverse transcription PCR (q-RT-PCR) (Table 2).
Volumes of 50 ml of B. breve UCC2003 and B. breve
UCC2003::838800 cultures, grown until the OD600 reached 0.5,
were exposed to sub-inhibitory concentrations of sodium
cholate for 1 h, and samples for RNA isolation were collected.
Methods for cell disruption, RNA isolation, cDNA synthesis
and indirect labelling for microarray hybridizations were per-
formed according to previously described procedures (Zomer
et al., 2009). DNA microarray data were processed as previ-
ously described (Zomer et al., 2009). A gene was considered
differentially expressed between a test condition and a
control when an expression ratio of > 3 or < 0.33 relative to
the result for the control was obtained with a corresponding
P-value that was < 0.001. Methods for gene expression
analysis through q-RT-PCR were performed according to
Gueimonde and colleagues (2009). For Northern hybridiza-
tion analysis of Bbr_0838 expression in B. breve UCC2003,
total RNA (20 mg) obtained from sodium cholate-exposed and
control cultures, was separated on a 1% (w/v) agarose/
0.66 M formaldehyde gel. Blotting, hybridization and washing
conditions were performed using a NorthernMax kit
(Ambion – Applied Biosystems), according to manufacturer’s
instructions. A biotinylated antisense-RNA probe encompass-
ing 951 bp of the Bbr_0838 coding sequence was generated
through in vitro transcription. To achieve this, an internal
fragment of Bbr_0838 was amplified using primers N838f and
N838r (Table 2). The amplified region was HindIII and XbaI
digested, and ligated into pBluescript-SK (Invitrogen). The
resulting construct was isolated from E. coli, HindIII linear-
ized, and used as a template for in vitro transcription with T7
RNA polymerase incorporating biotin-labelled dUTPs
(Roche). Post hybridization signal detection was accom-
plished using Streptavidin IRDye 680 conjugate and visual-
ized using the Odyssey imaging system (Li-Cor Biosciences,
Lincoln, NE, USA).
Plasmid constructions for promoter characterization
The key plasmids constructed in this work for Bbr_0838 pro-
moter characterization are listed in Table 2. DNA fragments of
Table 2. Primers used in this study.
Sequence Source
Promoter fragments
Prom838F2bglII 5′-GCTCGTAGATCTGCCTCGCATGTTCAGCTTCAC-3′ This work
Prom838FbglII 5′-GCTCGTAGATCTCATAGCCATCAACTTACG-3′ This work
Prom838F2BglIIshort 5′-CGAGTCAGATCTGGCATGCGTGGGTTTCAC-3′ This work
Prom838revBamHI + IR 5′-CGCATAGGATCCGATGAGTCCGGACGTAAAGG-3′ This work
Prom838revBamHI-IR 5′-CTGACTGGATCCGCGTAAGTTGATGGCTATG-3′ This work
Prom838rv + IRII50pstI 5′-CGTACAGCTGCAGGATGGGCCATCGGTACATC-3′ This work
Prom838rv + IRIIpstI 5′-CTATAGCCTGCAGCCGCTACACCAGCATCGAG-3′ This work
Prom838rv-IRIIpstI 5′-GTATACTCTGCAGCACGGCAGGCGCGTGCGATG-3′ This work
Prom838rv-pstI 5′-CTCACGCTGCAGGTGCGGATCAATAGGCTTTAC-3′ This work
Insertional mutation
838F 5′-TGCTCTAAGCTTCTTTCATGGTCGGCACACTG-3′ This work
838800R 5′-CGCGTCTAGAGAGATGGTCATGAGCGCAAGG-3′ This work
8381000R 5′-TCAACTTCTAGACATGTGCGAGGCGGTCACG-3′ This work
Mutant complementation
pBC-838-f 5′-CGATCGAAGCCTCGCATGTTCAGCTTCAC-3′ This work
pBC-838-r 5′-CGATGCGGATCCTTATCACCGATCATCCTTTGGGAAC-3′ This work
Primer extension
838pseqfor 5′-CATCTTGAACGCTTGAATGCCG-3′ This work
838pseqrev 5′-GCGCCATCCGAAACTGTCAATC-3′ This work
PE3 5′-GCGTAAGTTGATGGCTATGGTGAG-3′ This work
PE4 5′-CGATTCATGCGACGTCGACTGC-3′ This work
Northern probe f
N838f 5′-CCTAGCAAGCTTCGCCGTAGTGCCGATGCT-3′ This work
N838r 5′-GCTCAGTCTAGAGAACGCGATGCCTCTGG-3′ This work
q-RT-PCR
406-fq 5′-CACGCTGCTGCATGTAATCG-3′ Ruiz and colleagues (2011)
406-rq 5′-GCCAGCCTCGGTCATTTGTA-3′ Ruiz and colleagues (2011)
1805-fq 5′-CCTCCAACCGTAACTTCCTGAA-3′ Ruiz and colleagues (2011)
1805-rq 5′-CGACCTTGGCCAGCAGTTC-3′ Ruiz and colleagues (2011)
1827-fq 5′-CGCGGCTGGCACCAT-3′ Ruiz and colleagues (2011)
1827-rq 5′-TCATTGGTCATGTCCTTGAGCTT-3′ Ruiz and colleagues (2011)
832-fq 5′-TGCTGCATCTGGTGTTGATCTG-3′ Ruiz and colleagues (2011)
832-rq 5′-AAGCCGACCTCCGCATACC-3′ Ruiz and colleagues (2011)
1756-fq 5′-CTTCAATGCCACCGTGTATGG-3′ Ruiz and colleagues (2011)
1756-rq 5′-CGCCTGCTACTCCGGAAAC-3′ Ruiz and colleagues (2011)
Bbr838F 5′-CGCCCTGATCATCTGCATCT-3′ Ruiz and colleagues (2011)
Bbr838R 5′-TTGCGTGCGGCCTTCTC-3′ Ruiz and colleagues (2011)
Restriction sites are underlined.
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different lengths encompassing various segments of the
Bbr_0838 promoter region were used to construct transcrip-
tional fusions to the reporter gene gusA in the promoter-less
probe vector pNZ272 (Platteeuw et al., 1994). The DNA
region comprising the complete Bbr_0838 promoter was
amplified from B. breve UCC2003 chromosomal DNA using
primers Prom838rv-pstI and Prom838F2bglII. These primers
are complementary to the DNA sequence located in the 5′
end of Bbr_0838 coding sequence and 579 bp further
upstream from this point respectively. Amplified product was
digested using unique BglII and PstI restriction sites (primer-
introduced) and ligated into the similarly digested promoter
cloning vector pNZ272, resulting in the plasmid pNZ272-long.
The 5′ boundary of the promoter region was deduced
using PCR-derived sub-fragments. Primers annealing
424 bp (Prom838F2BglIIshort) and 162 bp (Prom838FbglII)
upstream from the 5′ end of Bbr_0838 respectively, were
used in combination with Prom838rv-pstI for PCR amplifica-
tion, using B. breve UCC2003 chromosomal DNA as a tem-
plate. Amplified fragments were BglII and PstI digested and
ligated into similarly digested pNZ272, yielding pNZ272ss
and pNZ272-short respectively.
Employing a similar approach, the promoter region
was minimized from 3′ end. Primers annealing 71 bp
(Prom838revBamHI + IR), 144 bp (Prom838revBamHI-IR),
190 bp (Prom838rv + IRII50pstI), 228 bp (Prom838rv +
IRIIpstI), and 296 bp (Prom838rv-IRIIpstI) upstream of
Bbr_0838 start codon respectively, were used in combination
with Prom838F2bglII for PCR amplification, using B. breve
UCC2003 chromosomal DNA as a template. Amplified
fragments were BglII and PstI or BamHI digested, and ligated
into similarly digested pNZ272, yielding to pNZ272-71,
pNZ272-144, pNZ272-190, pNZ272-228 and pNZ272-296
respectively.
All these constructs were initially electroporated into
L. lactis and DNA integrity of inserts was verified through
sequencing of plasmid minipreparations from positive clones.
Sequenced-verified constructs isolated from the correspond-
ing L. lactis clones were then introduced into electrocompe-
tent cells of B. breve UCC2003.
Measurement of b-D-glucuronidase activity
b-D-glucuronidase (GusA) activity was routinely determined
in cultures grown until mid-exponential growth phase, in the
presence of sub-inhibitory concentrations of sodium cholate
(0.025% w/v). Briefly, cells from 10 ml cultures were col-
lected, resuspended in 0.5 ml of PBS and disrupted with
glass-beads (Sigma) using a Fast-Prep, by five 15 s treat-
ments, with cooling intervals of 45 s when samples were put
on ice. After centrifugation, GusA activity was immediately
determined: Appropriate dilutions of the extracts (4 ml) were
mixed with 88 ml of sodium acetate 0.1 M and 8 ml of a 20 mM
solution of para-nitro-b-D-glucuronid acid (Sigma), and the
mixtures were incubated at 37°C. After 10 min, 100 ml of 1 M
ice-cold sodium carbonate was added to stop the reaction.
Optical density at 420 nm was measured and GusA activity
was determined measuring the para-nitrophenol (pNP)
released, quantified by a pNP standard curve. Protein con-
centration in extracts was measured by using the BCA protein
assay kit (Pierce, Rockford, IL, USA) and used to determine
GusA specific activity. One unit of enzymatic activity was
defined as the amount of protein that releases 1 nmol of pNP
per minute. Specific activities were expressed as units per
mg of protein and were measured in triplicate for each
extract. All data reported here represent the results of at least
three independent biological replicates.
Primer extension analysis
Primer extension was performed by annealing 1 pmol of
IRD800 synthetic oligonucleotides PE3 or PE4 to 20 mg of
RNA as described by Ventura and colleagues (2005).
Sequence ladders of the presumed Bbr_0838 promoter
regions, which were run alongside the primer extension prod-
ucts, were produced using the same primer as the primer
extension reaction and a PCR product template generated
using 838pseqfor and 838pseqrev. Thermo Sequenase
Primer Cycle Sequencing Kit (Healthcare Biosciences, Buck-
inghamshire, UK) was employed. Separation was achieved
on a 6.5% Li-Cor Matrix KB Plus acrylamide gel. Signal
detection and image capture was performed by means of a
Li-Cor sequencing instrument (Li-Cor Biosciences).
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